Table of contents
- IP and supplementary protection certificates
- European Parliament amends supplementary protection certificate rules
- Research and development
- European Medical Agency publishes responses to Draft ICH guideline S11
- Industry insights
- Regulators must stay vigilant against anti-vaccine movement in Europe
- Disputes
- Incorporation of jurisdiction clauses and service in the jurisdiction on defendants resident abroad (Idemia France SAS v Decatur Europe)
- Daily and weekly news alerts
- Dates for your diary
More sections of this document available when you sign-in to Lexis+ or register for a free trial.
Article summary
This week’s edition of Life Sciences highlights includes news that the European Parliament has approved amended rules on supplementary protection certificates and publication by the European Medicines Agency of comments on Draft ICH guideline S11 which deals with nonclinical safety testing for paediatric medicines.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial